Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter
Mario Mandalà, Giuseppe Curigliano, Paolo Bucciarelli et al. · Annals of Oncology · 2004
Cited by 63 works. doi:10.1093/annonc/mdh146 Open-access PDF
Authors
- Mario Mandalà
- Giuseppe Curigliano
- Paolo Bucciarelli
- Gianluigi Ferretti
- Pier Mannuccio Mannucci
- Marco Angelo Colleoni
- Andrea Ventura
- G. Peruzzotti
- Gianluca Severi
- Pier Giuseppe Pelicci
- Roberto Biffi
- Franco Orsi
- Saverio Cinieri
- Aron Goldhirsch
References
- Prevention of Venous Thromboembolism
- Mutation in blood coagulation factor V associated with resistance to activated protein C
- Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous Catheters
- Venous thrombosis: a multicausal disease
- Tumor angiogenesis and tissue factor
- Genetic Susceptibility to Venous Thrombosis
- Upper Extremity Deep Venous Thrombosis in Cancer Patients with Venous Access Devices - Prophylaxis with a Low Molecular Weight Heparin (Fragmin)
- Hemostatic alterations in cancer patients
- Cancer and venous thromboembolism
- A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L‐asparaginase